WHITE HORSE PHARMA LIMITED

Active London

Other human health activities

0 employees website.com
Other human health activities
W

WHITE HORSE PHARMA LIMITED

Other human health activities

Founded 3 Oct 2023 Active London, United Kingdom 0 employees website.com
Other human health activities
Accounts Submitted 3 Jul 2025 Next due 31 Jul 2026 1 month remaining
Confirmation Submitted 10 Oct 2025 Next due 24 Oct 2026 4 months remaining
Net assets £100
Total assets £100
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

Ground Floor 50 Pembroke Road London W8 6NX United Kingdom

Full company profile for WHITE HORSE PHARMA LIMITED (15183418), an active company based in London, United Kingdom. Incorporated 3 Oct 2023. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Nov → 31 Oct 2024
Type dormant
Next accounts 31 Oct 2025
Due by 31 Jul 2026 1 month remaining

Net Assets, Total Assets & Total Liabilities (2024–2024)

Cash in Bank

£100.00

Net Assets

£100.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Oct Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active
Status
Abeera ImranDirectorBritishEngland323 Oct 2023Active

Shareholders

Shareholders (4)

Lydden Holdings Ltd
100.0%
100
Lydden Holdings Ltd
100.0%
100

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Lydden Holdings Ltd

Unknown

Active
Notified 22 Sept 2025
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Abeera Imran

British

Active
Notified 3 Oct 2023
Residence England
DOB July 1993
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

WHITE HORSE PHARMA LIMITED Current Company
VNV PARTNERS LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Oct 2025Confirmation StatementConfirmation statement made on 10 Oct 2025 with updates
10 Oct 2025Persons With Significant ControlLydden Holdings Ltd notified as a person with significant control
3 Jul 2025AccountsAnnual accounts made up to 31 Oct 2024
18 Nov 2024Confirmation StatementConfirmation statement made on 25 Oct 2024 with no updates
26 Oct 2023Persons With Significant ControlChange to Dr Imran Abeera as a person with significant control on 25 Oct 2023
10 Oct 2025 Confirmation Statement

Confirmation statement made on 10 Oct 2025 with updates

10 Oct 2025 Persons With Significant Control

Lydden Holdings Ltd notified as a person with significant control

3 Jul 2025 Accounts

Annual accounts made up to 31 Oct 2024

18 Nov 2024 Confirmation Statement

Confirmation statement made on 25 Oct 2024 with no updates

26 Oct 2023 Persons With Significant Control

Change to Dr Imran Abeera as a person with significant control on 25 Oct 2023

Recent Activity

Latest Activity

Confirmation statement made on 10 Oct 2025 with updates

8 months ago on 10 Oct 2025

Lydden Holdings Ltd notified as a person with significant control

8 months ago on 10 Oct 2025

Annual accounts made up to 31 Oct 2024

11 months ago on 3 Jul 2025

Confirmation statement made on 25 Oct 2024 with no updates

1 years ago on 18 Nov 2024

Change to Dr Imran Abeera as a person with significant control on 25 Oct 2023

2 years ago on 26 Oct 2023